Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) Q3 2021 Earnings Conference Call November 2, 2021 5:00 PM ET Company Participants Joshua Higa - Director of Investor Relations and Corporate Communications Emil Kakkis - President, Chief Executive Officer and Director Erik Harris - Executive Vice President and Chief Commercial Officer Mardi Dier - Executive Vice President and Chief Financial Officer Camille Bedrosian - Chief Medical Officer & Executive Vice President Conference Call Participants Tazeen Ahmad - Ba ...

ultrageny Corporate Deck August 2, 2021 Legal Warning Cautionary note regarding forward-looking statements: This presentation contains forward-looking statements, including, but not limited to, statements regarding our expectations and projections regarding our future operating results and financial performance, anticipated cost or expense reductions, plans with respect to commercializing our product and product candidates, our translational research program, expectations regarding our manufacturing capabil ...

Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) Q1 2021 Earnings Conference Call July 30, 2021 5:00 PM ET Company Participants Joshua Higa - Director, IR Emil Kakkis - President and CEO Erik Harris - Chief Commercial Officer Camille Bedrosian - Chief Medical Officer Conference Call Participants Maury Raycroft - Jefferies Tazeen Ahmad - Bank of America Merrill Lynch Gena Wang - Barclays Joon Lee - Truist Securities Salveen Richter - Goldman Sachs Joseph Schwartz - SVB Leerink Cory Kasimov - JPMorgan Laura Chico ...

May 2021 Corporate Deck Legal Warning Cautionary note regarding forward-looking statements: This presentation contains forward-looking statements, including, but not limited to, statements regarding our expectations and projections regarding our future operating results and financial performance, anticipated cost or expense reductions, plans with respect to commercializing our product and product candidates, our translational research program, expectations regarding our manufacturing capabilities, the expec ...

Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) Q1 2021 Earnings Conference Call May 4, 2021 5:00 PM ET Company Participants Joshua Higa - Director, Investor Relations Emil Kakkis - President and CEO Camille Bedrosian - Chief Medical Officer Erik Harris - Chief Commercial Officer Mardi Dier - Chief Financial Officer Conference Call Participants Gena Wang - Barclays Tazeen Ahmad - Bank of America Yaron Werber - Cowen Dae Gon Ha - Stifel Yigal Nochomovitz - Citigroup Cory Kasimov - JPMorgan Maury Raycroft - Jeff ...

ultrageny? Corporate Deck February 2021 Legal Warning Cautionary note regarding forward-looking statements: This presentation contains forward-looking statements, including, but not limited to, statements regarding our expectations and projections regarding our future operating results and financial performance, anticipated cost or expense reductions, plans with respect to commercializing our product and product candidates, our translational research program, expectations regarding our manufacturing capabil ...

ultrageny? Corporate Deck February 2021 Legal Warning Cautionary note regarding forward-looking statements: This presentation contains forward-looking statements, including, but not limited to, statements regarding our expectations and projections regarding our future operating results and financial performance, anticipated cost or expense reductions, plans with respect to commercializing our product and product candidates, our translational research program, expectations regarding our manufacturing capabil ...

Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) Q4 2020 Earnings Conference Call February 11, 2021 5:00 PM ET Company Participants Joshua Higa - Director, Investor Relations Emil Kakkis - Chief Executive Officer and President Camille Bedrosian - Chief Medical Officer Erik Harris - Chief Commercial Officer Mardi Dier - Chief Financial Officer Conference Call Participants Yaron Werber - Cowen Gena Wang - Barclays Cory Kasimov - JPMorgan Joon Lee - Truist Securities Yigal Nochomovitz - Citigroup Liisa Bayko - Eve ...

January 2021 Corporate Deck Legal Warning Cautionary note regarding forward-looking statements: This presentation contains forward-looking statements, including, but not limited to, statements regarding our expectations and projections regarding our future operating results and financial performance, anticipated cost or expense reductions, plans with respect to commercializing our product and product candidates, our translational research program, expectations regarding our manufacturing capabilities, the e ...

November 2020 Corporate Presentation Legal Warning Cautionary note regarding forward-looking statements: This presentation contains forward-looking statements, including, but not limited to, statements regarding our expectations and projections regarding our future operating results and financial performance, anticipated cost or expense reductions, plans with respect to commercializing our product and product candidates, our translational research program, expectations regarding our manufacturing capabiliti ...